QA: Citius Pharmaceuticals Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001506251_2019_Citius_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001506251, Citius Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 10,060,078
1 IntangibleAssetsNetIncludingGoodwill 1,586,796
2 PropertyPlantAndEquipmentNet 1,483
3 remainder_Assets 19,402,167
4 LiabilitiesCurrent 3,184,840
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,212,581
9 ResearchAndDevelopmentExpense 9,530,591
10 remainder_Expenses 664,990
11 remainder_Revenues 0
12 remainder_NetIncome 1,100,426
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 31,050,524
1 Liabilities 3,184,840
2 Expenses 17,408,162
3 Revenues 0
4 StockholdersEquity 27,865,684
5 NetIncome -16,307,736
6 ComprehensiveNetIncome -16,307,736
7 BaseVar 26,371,976
8 EconomicCapitalRatiobeforeLimitedLiability 2.60
9 EconomicCapitalRatio 3.42

Edgar->Model Mapping

Feature Distribution

Change over Time